As the incidence of FHIT underexpression increases at the stage of carcinoma in situ, we have undertaken a preliminary examination of the cell environment associated with normal and abnormal FHIT expression in DCIS and invasive carcinoma using expression microarrays to evaluate the possible function of this protein in breast tissues. The gene discussed is FHIT; the disease is in situ carcinoma.